1. Home
  2. NVCR vs AAOI Comparison

NVCR vs AAOI Comparison

Compare NVCR & AAOI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NVCR
  • AAOI
  • Stock Information
  • Founded
  • NVCR 2000
  • AAOI 1997
  • Country
  • NVCR Switzerland
  • AAOI United States
  • Employees
  • NVCR N/A
  • AAOI N/A
  • Industry
  • NVCR Medical/Dental Instruments
  • AAOI Semiconductors
  • Sector
  • NVCR Health Care
  • AAOI Technology
  • Exchange
  • NVCR Nasdaq
  • AAOI Nasdaq
  • Market Cap
  • NVCR 1.4B
  • AAOI 1.6B
  • IPO Year
  • NVCR 2015
  • AAOI 2013
  • Fundamental
  • Price
  • NVCR $14.04
  • AAOI $31.84
  • Analyst Decision
  • NVCR Buy
  • AAOI Buy
  • Analyst Count
  • NVCR 7
  • AAOI 6
  • Target Price
  • NVCR $28.79
  • AAOI $28.40
  • AVG Volume (30 Days)
  • NVCR 1.9M
  • AAOI 5.4M
  • Earning Date
  • NVCR 10-30-2025
  • AAOI 11-06-2025
  • Dividend Yield
  • NVCR N/A
  • AAOI N/A
  • EPS Growth
  • NVCR N/A
  • AAOI N/A
  • EPS
  • NVCR N/A
  • AAOI N/A
  • Revenue
  • NVCR $630,160,000.00
  • AAOI $368,233,000.00
  • Revenue This Year
  • NVCR $6.68
  • AAOI $96.63
  • Revenue Next Year
  • NVCR $7.01
  • AAOI $62.31
  • P/E Ratio
  • NVCR N/A
  • AAOI N/A
  • Revenue Growth
  • NVCR 14.58
  • AAOI 77.94
  • 52 Week Low
  • NVCR $10.87
  • AAOI $9.71
  • 52 Week High
  • NVCR $34.13
  • AAOI $44.50
  • Technical
  • Relative Strength Index (RSI)
  • NVCR 60.46
  • AAOI 62.86
  • Support Level
  • NVCR $12.61
  • AAOI $24.79
  • Resistance Level
  • NVCR $14.77
  • AAOI $31.13
  • Average True Range (ATR)
  • NVCR 0.55
  • AAOI 2.48
  • MACD
  • NVCR 0.19
  • AAOI 0.30
  • Stochastic Oscillator
  • NVCR 67.68
  • AAOI 76.78

About NVCR NovoCure Limited

NovoCure Ltd is an oncology company with a propreitary platform technology in United States. Its business involves the development, manufacture and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis and other products and technologies for the treatment of Glioblastoma, Non-smell cell lung cancer and Pancreatic cancer. Geographically, the company derives majority of its revenue from the United States and rest from Germany, Japan and other markets.

About AAOI Applied Optoelectronics Inc.

Applied Optoelectronics Inc is a provider of fiber-optic networking products, for four networking end-markets; internet data center, CATV, telecom, and FTTH. The Company designs and manufactures a wide range of optical communications products at varying levels of integration, from components, subassemblies, and modules to complete turn-key equipment. Through direct sales personnel, and manufacturing teams in the United States, China, and Taiwan, the company coordinates with customers to determine product design, qualifications, and performance. The Company has manufacturing and research and development facilities located in the U.S., Taiwan, and China.

Share on Social Networks: